Abstract
A 15-year-old boy developed deep vein thrombosis of the right leg 9 days after appendectomy. In spite of three courses of thrombolysis with streptokinase and effective heparinization the thrombosis progressed with additional occlusion of the left iliac vein. Although platelet counts were constantly normal, heparin-associated thrombocytopenia was suspected as the cause of the new venous occlusions. This diagnosis was confirmed by detecting heparin-associated antibodies with the heparin-induced platelet activation test.
Therapy was instituted replacing heparin by the low molecular weight heparinoid Orgaran. Bilateral recanalization occurred within 6 days.
Similar content being viewed by others
Abbreviations
- HAT :
-
heparin associated thrombocytopenia
- HIPA test :
-
heparin-induced platelet activation test
- LMW :
-
low molecular weight
- r-tPA :
-
recombinant tissue plasminogen activator
References
Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95–96
Chesney CM, Lands RH (1987) Thrombosis in patients with heparin-induced thrombocytopenia. Thromb Haemost a58:308
Chong BH, Berndt MD (1989) Heparin-induced thrombocytopenia. Blut 58:53–57
Chong BH, Magnani HN (1992) Orgaran in heparin-induced thrombocytopenia. Haemostasis 22:85–91
Chong BH, Fawaz I, Cade J, Gallus AS, Chesterman CN (1989) Heparin induced-thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172. Blood 73:1592–1596
Cines DB, Tomaski A, Tannenbaum S (1987) Immune endothelial-cell injury in heparin associated thrombocytopenia. N Engl J Med 316:581–589
Cola C, Ansell J (1990) Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies. Am Heart J 119:368–374
Greinacher A, Mueller-Eckhardt C (1991) Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wochenschr 116:1479–1482
Greinacher A, Mueller-Eckhardt C (1991) Therapie der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wochenschr 116:1483–1484
Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C (1991) A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 66:734–736
Greinacher A, Michels I, Schäfer M, Kiefel V, Mueller-Eckhardt C (1992) Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan. Br J Haematol 81:252–254
Greinacher A, Drost W, Michels I, Leitl J, Gottsmann M, Kohl HJ, Glaser M (1992) Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing crossreaction to LMW heparins. Ann Hematol 64:40–42
Greinacher A, Michels I, Mueller-Eckhardt C (1992) Heparin-associated thrombocytopenia: The antibody is not heparin specific. Thromb Haemost 67:545–54
Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C (1994) Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247–251
Greinacher A, Amiral J, Dummel V, Vissac AM, Kiefel V, Mueller-Eckhardt C (1994) Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34:381–385
Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B (1994) Heparin-associated thrombosis despite normal platelet counts. Lancet 344:469–470
Kappa JR, Fischer CA, Berkowitz HD, Cottrell ED, Addonizio VP (1987) Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management. J Vasc Surg 5:101–109
King DJ, Kelton JG (1984) Heparin associated thrombocytopenia. Ann Intern Med 100:535–540
Levy M, Benson LN, Burrows PE, Bentur Y, Strong DK, Smith J, Johnson D, Jacobson S, Koren G (1991) Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 118: 467–472
Magnani HN (1993) Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 70: 554–561
Meuleman DG (1992) Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis 22: 58–65
Murdoch IA, Beattie RM, Silver DM (1993) Heparin-induced thrombocytopenia in children. Acta Paediatr 82: 495–497
Oriot D, Wolfe M, Wood C, Brun P, Sidi D, Devictor D, Tchernia G, Huault G (1990) Thrombopénie sévère induite par l'héparine chez un nourrisson porteur d'une myocardite aigue. Arch Fr Pediatr 47:357–359
Phelan BK (1983) Heparin-associated thrombosis without thrombocytopenia. Ann Intern Med 99:637–638
Potter C, Gill JC, Scott JP, McFarland JG (1992) Heparin-induced thrombocytopenia in a child. J Pediatr 121:135–138
Rosenbaum T, Rammos S, Kniemeyer HW, Göbel U (1993) Extended deep vein and inferior vena cava thrombosis in an 15-year-old boy; successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms. Eur J Pediatr 152: 978–980
Sheridan D, Carter C, Kelton JG (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood 67: 27–30
Spadone D, Clark F, James E, Laster J, Hoch J, Silver D (1992) Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 15:306–311
Visentin GP, Ford SE, Scott JP, Aster RH (1994) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81–88
Warkentin TE, Kelton JG (1989) Heparin-induced thrombocytopenia. Ann Rev Med 40:31–44
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klement, D., Rammos, S., v. Kries, R. et al. Heparin as a cause of thrombus progression. Eur J Pediatr 155, 11–14 (1996). https://doi.org/10.1007/BF02115618
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02115618